Laboratorios Farmaceutico... (LABFF)

PNK: LABFF · Real-Time Price · USD

90.61

0.00 (0.00%)

At close: May 01, 2025, 8:00 PM

Laboratorios Farmaceuticos Rovi S.A. Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	27.19M	25.32M	124.94M	99.03M	53.16M	67.43M	95.51M	40.7M	41.38M
Short-Term Investments	227K	113K	-65K	-65K	-65K	-65K	67K	47K	32K
Long-Term Investments	19.29M	591K	2.27M	2.13M	1.95M	1.98M	2.17M	2.19M	2.83M
Other Long-Term Assets	292K	8.57M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	124.55M	160.23M	129.8M	63.34M	71.67M	51M	41.12M	45.33M
Inventory	329.95M	337.97M	311.94M	245.47M	227.2M	158.81M	94.86M	75.49M	67.39M
Other Current Assets	132.24M	18.65M	23.84M	30.16M	20.8M	19.9M	12.54M	10.81M	12.95M
Total Current Assets	489.61M	509.33M	623.07M	506.36M	364.58M	317.88M	254M	168.17M	167.07M
Property-Plant & Equipment	286.62M	253.65M	215.54M	181.78M	155.4M	131.61M	95.84M	89.06M	82.82M
Goodwill & Intangibles	33.95M	27.74M	35.74M	38.56M	41.41M	45.08M	34.65M	27.08M	24.87M
Total Long-Term Assets	342.42M	290.55M	255.63M	226.31M	209.86M	193.33M	148.7M	130.22M	120.78M
Total Assets	832.02M	799.88M	878.7M	732.68M	574.44M	511.21M	402.7M	298.38M	287.85M
Account Payables	86.85M	107.59M	125.87M	99.4M	65.19M	70.07M	49.84M	43.4M	50.78M
Deferred Revenue	n/a	n/a	114.9M	57.63M	25.5M	1.57M	1.16M	79K	169K
Short-Term Debt	17.84M	8.06M	8.24M	2.96M	2.95M	9.24M	17.64M	16.21M	12.97M
Other Current Liabilities	5.25M	46.29M	123.65M	59.99M	27.83M	13.68M	8.99M	1.51M	1.63M
Total Current Liabilities	156.65M	199.84M	293.89M	190.39M	122.89M	106.71M	87.51M	73.22M	76.44M
Long-Term Debt	80.5M	38.58M	46.04M	52.52M	53.94M	54.69M	16.59M	27.03M	20.83M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	93.83M	56.55M	63.44M	71.31M	77.85M	82.12M	27.72M	33.47M	28M
Total Liabilities	250.48M	256.39M	357.32M	261.7M	200.74M	188.82M	115.23M	106.69M	104.44M
Total Debt	114.41M	65.43M	72.14M	73.14M	73.52M	84.68M	34.22M	43.24M	33.79M
Common Stock	3.07M	3.24M	3.24M	3.36M	3.36M	3.36M	3.36M	3M	3M
Retained Earnings	486.21M	555.53M	456.03M	445.43M	302.21M	241.06M	204.69M	196.5M	188.51M
Comprehensive Income	n/a	-21K	665K	671K	670K	670K	597K	598K	597K
Shareholders Equity	572.03M	539.39M	520.01M	470.98M	373.7M	322.39M	287.47M	191.69M	183.41M
Total Investments	19.52M	591K	2.2M	2.07M	1.88M	1.91M	2.11M	2.12M	2.64M